D.C. finalizes medical cannabis advertising and signage rules after extended emergency rulemakings
The Alcoholic Beverage and Cannabis Board adopted final rules tightening medical cannabis advertising and signage standards, concluding a rulemaking process that began with emergency legislation in early 2024. The amendments to Title 22 of the D.C. Municipal Regulations establish new square footage limits for exterior signs, restrict window coverage, prohibit signage on entrance and exit doors, and bar businesses — licensed or unlicensed — from misrepresenting compliance with the District’s 2014 cannabis initiative.
- The next ABC Board meeting is Feb. 25, 2026: watch, agenda.
- Feb. 11 disposition.
Virginia CCA launches public medical cannabis data dashboard
The Virginia Cannabis Control Authority has launched a new Medical Cannabis Program Dashboard, giving patients, providers, and policymakers real-time insight into how Virginia’s medical cannabis market is performing. The public tool displays key data pulled from the state’s seed-to-sale system, including total sales, average flower prices, product category breakdowns, and plant harvest numbers — all aimed at increasing transparency and accessibility.
- Virginia lawmakers in the General Assembly advanced legislation to establish a legal adult-use cannabis retail framework after years of vetoes and stalemates, with separate bills approved by both the House and Senate that position the state to finally implement a regulated market. The measures, now likely to be signed by Gov. Abigail Spanberger, aim to transition Virginia from legal possession without sales toward regulated retail sales as early as late 2026 or early 2027, ending the long absence of a legal marketplace.
- Catch up on the Feb. 17th CCA meeting here. The next meeting should be in March.
Maryland ends enhanced reporting for Seven Points Agro Therapeutics
Maryland regulators have terminated enhanced reporting requirements for Seven Points Agro Therapeutics, LLC, concluding oversight tied to a 2023 Consent Order (Case No. 23-00347). The company had agreed to pay a $62,000 civil penalty and comply with heightened quarterly reporting — including green waste logs and inventory documentation — for two years following regulatory charges issued in September 2023. After reviewing the company’s compliance performance, the Maryland Cannabis Administration approved a January 2026 request to end the additional reporting early. A February 2 order confirms the termination, closing out the matter from a regulatory monitoring standpoint.
East Coast Roundup
New York State authorities seized more than $2 million worth of unlicensed cannabis products in coordinated enforcement actions in Brooklyn and Rhinebeck, shutting down illegal operations and emphasizing ongoing efforts to protect the regulated market.
An opinion piece in The Harvard Independent argues that The New York Times is incorrect to take a more cautious stance on cannabis legalization, asserting that economic benefits and state‑level regulatory control outweigh concerns about public health and market impacts.
State cannabis regulators padlocked an illegal Dutchess County cannabis shop and seized over $900,000 in untested products as part of broader crackdowns on unlicensed marijuana operations undermining New York’s legal market.
Adult‑use cannabis establishments in Massachusetts have surpassed $9 billion in cumulative gross sales since legalization, driven by robust retail demand and recent record revenue, highlighting the economic impact of the regulated cannabis industry.
Culture & More
Cannabis smoke filled the air during the annual Shivaratri festival in Nepal, where thousands of devotees openly used cannabis in culturally traditional celebrations despite its general illegality outside the event.
The University of California, Los Angeles received approximately $7.3 million in state cannabis research funding to support multiple studies on cannabinoids’ medical applications, health effects, and unregulated market risks.
The Cannabis Musings newsletter’s February 17, 2026 edition dissects a legal ruling enforcing a multimillion‑dollar judgment in favor of Canaccord Genuity against a cannabis executive, illustrating industry complexities with corporate finance and stock‑based margin loans.
A Killing in Cannabis by Scott Eden explores the 2019 murder of a cannabis entrepreneur in Santa Cruz, revealing the dangerous overlap between legal cannabis markets, black‑market capital, and organized crime in California’s emerging industry.
Around the Country
Sponsors of a Florida adult‑use cannabis legalization ballot initiative are urging the state Supreme Court to review lower‑court decisions that could block their petition from qualifying for the 2026 ballot amid a signature‑validation dispute.
South Dakota lawmakers blocked legislative efforts to dismantle the state’s medical marijuana program, preserving access for patients amid ongoing political debates over cannabis policy reform.
Texas expanded its Compassionate Use Program to allow more patients access to higher‑THC medical cannabis products, intensifying debate over the pace and scope of reform in the largely restrictive market.
Colorado’s cannabis retail sales declined for a second consecutive month, signaling potential market saturation or shifting consumer behavior in one of the nation’s most mature adult‑use markets.
A 37‑pound marijuana seizure in Belgrade, Montana has drawn attention to the strength of the state’s unlicensed cannabis market and ongoing enforcement gaps following legalization.
From the swamp
Former Reagan–era drug czar William “Bill” Bennett publicly broke with President Trump’s administration over its move to ease federal marijuana restrictions — including rescheduling cannabis away from Schedule I — arguing the policy shift undermines anti‑drug efforts and harms youth despite Trump’s executive order aimed at expanding research and loosening federal controls.
